posted on Jan, 9 2023 @ 05:13 PM
a reply to:
vNex92
The medication he was eventually given--Dupilumab--is used for treatment of atopic dermatitis and apparently made his condition a lot better.
"New York (December 31, 2014) For the first time, a team led by researchers at the Icahn School of Medicine at Mount Sinai has proven that atopic
dermatitis, also known as eczema, is an immune-driven (autoimmune) disease at the molecular level. The study, a collaboration with Regeneron
Pharmaceuticals, Sanofi and Rockefeller University, was published online earlier this month in the Journal of Allergy and Clinical Immunology.
Past studies had shown that drugs which broadly suppress the immune system reduce symptoms in patients with the disease, but the field had not
described in detail the molecular mechanisms involved. Some researchers had argued in the past that genetic or environmental factors were the greater
contributors to risk.
In the current study, Emma Guttman-Yassky, MD, PhD, Associate Professor of Dermatology at the Icahn School of Medicine at Mount Sinai and her team of
researchers found that dupilumab, a monoclonal antibody treatment that blocks the action of two key signaling proteins, interleukin (IL)-4 and
-13,—reversed disease processes seen in the skin of patients at the molecular level. Dupilumab is an experimental drug being development by study
partner Regeneron Pharmaceuticals that is currently in clinical trials for several conditions with immune or autoimmune mechanisms."
www.mountsinai.org...
It seems very likely that he had an autoimmune reaction to the vaccine, IMHO.